Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minetta C Liu

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
The Oncologist|July 16, 2024
Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinomaAndres F Correa, Ekaterina Kalashnikova, Hsin-Ta Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNAXiaoji Chen, Zhao Dong, Earl Hubbell, et al.
Cancer|January 4, 2026
Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancersRutika Mehta, Samuel Rivero-Hinojosa, Farshid Dayyani, et al.
Breast Cancer Research and Treatment|October 21, 2024
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108Vered Stearns, Anne ONeill, Bryan P Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinomaJu Dong Yang, Michael B Campion, Minetta C Liu, et al.
JCO Precision Oncology|December 18, 2024
Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell CarcinomaArnab Basu, Cherry Au, Ajitha Kommalapati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 5, 2026
The landscape of genomic and socioeconomic variables in colorectal cancer patients based on genetic ancestryPreethi Srinivasan, Sara L Bristow, Fernando L Mendez, et al.
Nature Communications|July 24, 2025
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker studyAziz Zaanan, Audrey Didelot, Chloé Broudin, et al.
JCO Precision Oncology|September 24, 2025
Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine CancerPeter W Ketch, Carly Bess Scalise, Fernando Recio, et al.
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
The Oncologist|July 16, 2024
Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinomaAndres F Correa, Ekaterina Kalashnikova, Hsin-Ta Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNAXiaoji Chen, Zhao Dong, Earl Hubbell, et al.
Cancer|January 4, 2026
Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancersRutika Mehta, Samuel Rivero-Hinojosa, Farshid Dayyani, et al.
Breast Cancer Research and Treatment|October 21, 2024
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108Vered Stearns, Anne ONeill, Bryan P Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinomaJu Dong Yang, Michael B Campion, Minetta C Liu, et al.
JCO Precision Oncology|December 18, 2024
Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell CarcinomaArnab Basu, Cherry Au, Ajitha Kommalapati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 5, 2026
The landscape of genomic and socioeconomic variables in colorectal cancer patients based on genetic ancestryPreethi Srinivasan, Sara L Bristow, Fernando L Mendez, et al.
Nature Communications|July 24, 2025
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker studyAziz Zaanan, Audrey Didelot, Chloé Broudin, et al.
JCO Precision Oncology|September 24, 2025
Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine CancerPeter W Ketch, Carly Bess Scalise, Fernando Recio, et al.
Pageof 16